CureVac is a Germany-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $132.1M
Employees: 501-1,000
Address: Friedrich-Miescher-Str. 15
City: Tubingen
State: baden-württemberg
Zip: 72076
Country: DE
CureVac is a Germany-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/14/2020
IPO Valuation:
$3B
Ticker Symbol:
CVAC
IPO Price:
$16/share
Amount Raised:
$213M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
6/2022 | Frame Cancer Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|